Preclinical evaluation of brimonidine
- 30 November 1996
- journal article
- review article
- Published by Elsevier in Survey of Ophthalmology
- Vol. 41, S9-S18
- https://doi.org/10.1016/s0039-6257(96)82027-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Analogs of UK 14,304: Structural features responsible for α2 adrenoceptor activityBioorganic & Medicinal Chemistry Letters, 1995
- Apraclonidine and Brimonidine Effects on Anterior Ocular and Cardiovascular Physiology in Normal and Sympathectomized MonkeysExperimental Eye Research, 1994
- Secondary mechanisms in neuronal traumaCurrent Opinion in Neurology, 1994
- Analogs of UK 14,304 as α2-adrenoceptor agonists. Twist and agent polarity as design elements.Bioorganic & Medicinal Chemistry Letters, 1994
- Neuroprotection by the α2-Adrenoreceptor Agonist Dexmedetomidine in a Focal Model of Cerebral IschemiaAnesthesiology, 1993
- Effect of Apraclonidine on Intraocular Pressure in Glaucoma Patients Receiving Maximally Tolerated MedicationsJournal of Glaucoma, 1992
- Corneal and Conjunctival/Scleral Penetration of p-Aminoclonidine, AGN 190342, and Clonidine in Rabbit EyesCurrent Eye Research, 1990
- The Safety and Efficacy of Topical 1% ALO 2145 (p-Aminoclonidine Hydrochloride) in Normal VolunteersArchives of Ophthalmology (1950), 1987
- Ocular effects of a relatively selective α2 agonist (UK-14, 304-18) in cats, rabbits and monkeysCurrent Eye Research, 1986
- UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypesEuropean Journal of Pharmacology, 1981